141 related articles for article (PubMed ID: 37673913)
1. A new class of anticancer activity with computational studies for a novel bioactive aminophosphonates based on pyrazole moiety.
Baren MH; Ibrahim SA; Al-Rooqi MM; Ahmed SA; El-Gamil MM; Hekal HA
Sci Rep; 2023 Sep; 13(1):14680. PubMed ID: 37673913
[TBL] [Abstract][Full Text] [Related]
2. Synthesis, Cytotoxicity Evaluation, Molecular Docking and Utility of Novel Chalcones as Precursors for Heterocycles Incorporating Pyrazole Moiety.
Gomha SM; Abdallah MA; Abbas IM; Kazem MSH
Med Chem; 2018; 14(4):344-355. PubMed ID: 29065841
[TBL] [Abstract][Full Text] [Related]
3. Annulated pyrazole derivatives as a novel class of urokinase (uPA) inhibitors: Green synthesis, anticancer activity, DNA-damage evaluation, and molecular modelling study.
Farag PS; AboulMagd AM; Hemdan MM; Hassaballah AI
Bioorg Chem; 2023 Jan; 130():106231. PubMed ID: 36335649
[TBL] [Abstract][Full Text] [Related]
4. Dual EGFR/VEGFR2 inhibitors and apoptosis inducers: Synthesis and antitumor activity of novel pyrazoline derivatives.
Alkamaly OM; Altwaijry N; Sabour R; Harras MF
Arch Pharm (Weinheim); 2021 Apr; 354(4):e2000351. PubMed ID: 33252142
[TBL] [Abstract][Full Text] [Related]
5. Synthesis of Asymmetric 1-Thiocarbamoyl Pyrazoles as Potent Anti- Colon Cancer, Antioxidant and Anti-Inflammatory Agent.
Raut DG; Patil SB; Kadu VD; Hublikar MG; Bhosale RB
Anticancer Agents Med Chem; 2018; 18(15):2117-2123. PubMed ID: 30417799
[TBL] [Abstract][Full Text] [Related]
6. Synthesis, Characterization, Antimicrobial Activity and Anticancer of Some New Pyrazolo[1,5-a]pyrimidines and Pyrazolo[5,1-c]1,2,4-triazines.
Hosny MA; Zaki YH; Mokbel WA; Abdelhamid AO
Med Chem; 2020; 16(6):750-760. PubMed ID: 31218963
[TBL] [Abstract][Full Text] [Related]
7. Molecular Docking, G-QSAR Studies, Synthesis and Anticancer Screening of Some New 2-Phenazinamines as Bcr-Abl Tyrosine Kinase Inhibitors.
Kale MA; Sonwane GM
Curr Drug Discov Technol; 2020; 17(2):213-224. PubMed ID: 30210004
[TBL] [Abstract][Full Text] [Related]
8. New pyrazoles incorporating pyrazolylpyrazole moiety: synthesis, anti-HCV and antitumor activity.
Riyadh SM; Farghaly TA; Abdallah MA; Abdalla MM; Abd El-Aziz MR
Eur J Med Chem; 2010 Mar; 45(3):1042-50. PubMed ID: 20022411
[TBL] [Abstract][Full Text] [Related]
9. Synthesis, EGFR Inhibition and Anti-cancer Activity of New 3,6-dimethyl-1-phenyl-4-(substituted-methoxy)pyrazolo[3,4-d] pyrimidine Derivatives.
Bakr RB; Mehany ABM; Abdellatif KRA
Anticancer Agents Med Chem; 2017; 17(10):1389-1400. PubMed ID: 28270084
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and potent antimicrobial activity of novel coumarylthiazole α-aminophosphonates derivatives.
Litim B; Cheraiet Z; Meliani S; Djahoudi A; Boukhari A
Mol Divers; 2022 Apr; 26(2):1161-1174. PubMed ID: 34117993
[TBL] [Abstract][Full Text] [Related]
11. Synthesis of novel 3,5-diaryl pyrazole derivatives using combinatorial chemistry as inhibitors of tyrosinase as well as potent anticancer, anti-inflammatory agents.
Bandgar BP; Totre JV; Gawande SS; Khobragade CN; Warangkar SC; Kadam PD
Bioorg Med Chem; 2010 Aug; 18(16):6149-55. PubMed ID: 20638287
[TBL] [Abstract][Full Text] [Related]
12. New pyrimidine and pyrazole-based compounds as potential EGFR inhibitors: Synthesis, anticancer, antimicrobial evaluation and computational studies.
Othman IMM; Alamshany ZM; Tashkandi NY; Gad-Elkareem MAM; Anwar MM; Nossier ES
Bioorg Chem; 2021 Sep; 114():105078. PubMed ID: 34161878
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and anticancer activity of some novel fused pyridine ring system.
Elansary AK; Moneer AA; Kadry HH; Gedawy EM
Arch Pharm Res; 2012 Nov; 35(11):1909-17. PubMed ID: 23212632
[TBL] [Abstract][Full Text] [Related]
14. Design, Synthesis, Anticancer Evaluation, Enzymatic Assays, and a Molecular Modeling Study of Novel Pyrazole-Indole Hybrids.
Hassan AS; Moustafa GO; Awad HM; Nossier ES; Mady MF
ACS Omega; 2021 May; 6(18):12361-12374. PubMed ID: 34056388
[TBL] [Abstract][Full Text] [Related]
15. Synthesis, anticancer assessment on human breast, liver and colon carcinoma cell lines and molecular modeling study using novel pyrazolo[4,3-c]pyridine derivatives.
Metwally NH; Deeb EA
Bioorg Chem; 2018 Apr; 77():203-214. PubMed ID: 29367077
[TBL] [Abstract][Full Text] [Related]
16. Synthesis, in vitro anticancer activity and in silico studies of certain isoxazole-based carboxamides, ureates, and hydrazones as potential inhibitors of VEGFR2.
Abou-Seri SM; Eissa AAM; Behery MGM; Omar FA
Bioorg Chem; 2021 Nov; 116():105334. PubMed ID: 34534755
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and biological validation of novel pyrazole derivatives with anticancer activity guided by 3D-QSAR analysis.
Vujasinović I; Paravić-Radičević A; Mlinarić-Majerski K; Brajša K; Bertoša B
Bioorg Med Chem; 2012 Mar; 20(6):2101-10. PubMed ID: 22341245
[TBL] [Abstract][Full Text] [Related]
18. New series of fused pyrazolopyridines: Synthesis, molecular modeling, antimicrobial, antiquorum-sensing and antitumor activities.
El-Gohary NS; Hawas SS; Gabr MT; Shaaban MI; El-Ashmawy MB
Bioorg Chem; 2019 Nov; 92():103109. PubMed ID: 31521987
[TBL] [Abstract][Full Text] [Related]
19. Synthesis of Novel Thieno[2,3-d]pyrimidine Derivatives and Evaluation of Their Cytotoxicity and EGFR Inhibitory Activity.
Adly ME; Gedawy EM; El-Malah AA; El-Telbany FA
Anticancer Agents Med Chem; 2018; 18(5):747-756. PubMed ID: 29366427
[TBL] [Abstract][Full Text] [Related]
20. Part I: Design, synthesis and biological evaluation of novel pyrazole-benzimidazole conjugates as checkpoint kinase 2 (Chk2) inhibitors with studying their activities alone and in combination with genotoxic drugs.
Galal SA; Abdelsamie AS; Shouman SA; Attia YM; Ali HI; Tabll A; El-Shenawy R; El Abd YS; Ali MM; Mahmoud AE; Abdel-Halim AH; Fyiad AA; Girgis AS; El-Diwani HI
Eur J Med Chem; 2017 Jul; 134():392-405. PubMed ID: 28433679
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]